![Lars Åke Malmsten](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dr. Lars Å.
Malmsten is Chief Executive Officer, Director & Head-Project at LIDDS AB. He is on the Board of Directors at LIDDS AB and Laccure AB.
Dr. Malmsten was previously employed as Chief Executive Officer by Camurus AB and Chief Executive Officer by SkyePharma Plc.
He received his doctorate degree from the University of Lund.
| Unternehmen | Position | Ende |
|---|---|---|
Laccure AB
 Laccure AB Pharmaceuticals: GenericHealth Technology Develops products for treatment of bacterial vaginosis in the field of skin care and hygiene activities | Direktor/Vorstandsmitglied | - |
| CAMURUS AB | Vorstandsvorsitzender | - |
| SKYEPHARMA PLC | Vorstandsvorsitzender | - |
| LIDDS AB | Vorstandsvorsitzender | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 5 |
|---|---|
SkyePharma Plc
 SkyePharma Plc Pharmaceuticals: OtherHealth Technology Manufactures and develops oral and inhalation pharmaceutical products | Health Technology |
Camurus AB
 Camurus AB Pharmaceuticals: MajorHealth Technology Provides nanoscale drug delivery systems for development of high value therapeutics | Health Technology |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LIDDS AB
 LIDDS AB Pharmaceuticals: MajorHealth Technology Focuses on the development of treatment alternatives and hormonal therapy for prostate cancer | Health Technology |
Laccure AB
Laccure AB Pharmaceuticals: GenericHealth Technology Develops products for treatment of bacterial vaginosis in the field of skin care and hygiene activities | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
